at -253 to -248, and a hybrid site containing a CRE-like element (CREL; TGAC-CTCA, -189 to -182) adjacent to an equally transcriptionally active octamer (0) sequence (ATG-CAAAT, -181 to -154). These three motifs acted synergistically and their transcriptiohal activity was completely dependent on CAMP. In HeLa cells their synergistic activity was more constitutive than CAMP induced, whereas in CT-negative MTC cells (the RO-D81-1 line) these motifs were inactive.
Gel mobility shift assays with antibodies against CRE-binding protein (CREB) and activating transcription factor 1 (ATF-1) showed that both CREB and ATF-1 interacted with the CRE in MTC cells, whereas in HeLa cells only ATF-1 bound to the CRE. Specific binding to the CREUO motif was detectable in extracts from tumors induced by injection of TT cells but not in extracts from any of the three cultured cell lines. We conclude that CAMP-induced transcription of the CT gene is modulated in a cell-specific manner by the CRE and the CREUO elements.
(Molecular Endocrinology 9: 784-793, 1995)
INTRODUCTION
The gene encoding calcitonin (Cl) and CT-generelated-peptide is expressed in neuronal and thyroid C cells (1). It is also expressed in neoplasms derived from neuroendocrine cells, such as medullary thyroid carcinoma (MTC) (2).
We and others previously demonstrated that transcription of the CT gene in transformed C cells (IT cells) is modulated by a distal neuroendocrine-specific enhancer and a proximal CAMP-induced enhancer. The distal enhancer is responsible for cell-restricted basal expression of the gene, whereas the proximal enhancer is responsible for CAMP-induced transcription (3, 4). We showed previously that the two enhancers can function independently but together act in synergism. Vitamin D down-regulates the CT gene, probably by interfering with this synergistic interaction (5). The distal elements involved in this interaction are two CANNTG motifs, which are potential binding sites for helix-loop-helix proteins (6). To date, the functional &-acting elements within the proximal CAMP-induced enhancer have not been clearly identified. To understand better the mechanism of CAMP-induced transcription and the synergistic interaction between the two enhancers, we had to identify the functional &-acting elements within the CAMP-induced enhancer and characterize the proteins that bind to these proximal elements. A computer analysis of the CAMP-induced enhancer region (-255 to -85) revealed multiple sequences that may function as binding sites for CAMP-regulated transcription factors (7, 8) . These include a CAMP responsive element (CRE) that may be a binding site for members of the CREB/ATF family (9-l 1); a CRE-like (CREL) motif, one base different from CRE, flanked by two octamer sequences (0) that are potential binding sites for home01 Pit-l, OTF 1 and 2, and UNC 86 (POU) domain proteins (12-16); and two potential activator protein (AP)-2 binding sites (17) (Fig. 1) . 
T' XCC C T G G G I Fig. 1 . Structure of the CT CAMP-Induced Enhancer Region Shown are the locations of the sequences that are potential binding sites for CAMP-regulated transcription factors. The consensus sequences (upper sequences in each box) and their homologs (lower sequences) within the CAMP-induced enhancer are given. Pit-l, Pituitary-specific transcription factor from the homeo/POU domain family (12-14); Ott 1-6, octamer-binding proteins that are members of the homeo/POU domain family (15, 16) .
In this study, we further analyzed CT CAMP-induced enhancer function in CT-expressing and CT-negative tumor lines and mapped the functional &-acting elements within this enhancer region using DNA transfer techniques (4, 5). Furthermore, we began characterizing the CAMP enhancer-binding proteins using electrophoretic mobility shift assays and specific antibodies against members of the CREB/ATF family of transcription factors.
RESULTS
Mapping the Functional c&-Acting Elements within the CAMP-Induced CT Enhancer
In previous studies, we showed that the CT 5'-flanking DNA contained a proximal CAMP-induced enhancer that functioned independently of and synergized with a distal constitutive enhancer (5). To map functional cis-acting elements within the CAMP-induced enhancer, it was necessary to test their activities independently of the constitutive enhancer elements. Therefore, we created the construct pCAMP-1, which lacked the basal enhancer but contained the potential CAMP-induced enhancer elements shown in Fig. 1 . Then, we prepared a series of mutant constructs by sequential 5'-deletion of the pCAMP-1 and by introducing point mutations in the potential cis-acting elements. These constructs were transfected into lT cells (18) and their activities were tested before and after addition of the CAMP analog. The CAMP-induced activity of these mutants was expressed as a percentage of the CAMP-induced activity of pCAMP-1 and not as fold induction of basal promoter activity because in TT cells this activity was undetectable.
In TT cells, we detected an approximately S-55% loss in CAMP-induced transcription when the upstream CRE (TGACGTCA) motif was deleted or mutated (Fig. 2) . Deletion of CT nucleotides -247 to -175, which includes the potential upstream AP-2 site and part of the upstream octamer sequence, had no further effect on cAMP?nduced transcription.
There was an additional 2530% loss of CAMP-induced activity when the CREL (TGACCTCA) site was mutated or when CT nucleotides -175 ,to -129 were deleted. Similar results were obtained"by mutating or deleting the adjacent downstream octamer ATGCAAAT sequence. 'Hence the hybrid element TGACCTCAATGCAAAT is now identified as CREUO. Interestingly, a mutation of the CREUO motif in a construct containing the CRE (pCAMP-7) reduced CAMP-induced transcription by 80%. These results suggest that the CREUO element was essential for transcriptional activity of the CRE even though the CREUO element could also function independently of the CRE in lT cells. Figure 2C demonstrates the inverse relationship between passage number and the CAMP-induced activity of CREUO. At early passages (30-40), this motif contributed 80% of CAMP-induced transcription, whereas at later passages (170) (171) (172) (173) (174) (175) (176) (177) (178) (179) (180) it contributed only 20% of this activity. Taken together, these results suggest that in lT cells CAMP-induced transcription of the CT gene is due to a CRE and to another, equally important, hybrid element (CREUO) containing both a CREL motif and an octamer motif. (Fig. 3) . In HeLa cells, transcriptional activity of pCAMP-1 was primarily constitutive and was not augmented by addition of the CAMP analog. Mutating CRE in the presence of CREUO (construct pCAMP-2) or mutating CREUO in the presence of CRE (construct pCAMP-7) diminished transcription by 90%. Similar results were obtained by deleting the CRE. We concluded that in HeLa cells as in TT cells, the transcriptional activity of the CRE was dependent on CREUO. On the other hand, while CREUO was somewhat active in lT cells in the absence of CRE, it did not act independently in HeLa.
In RO-D81-1 cells, transcription of the constructs tested was mainly constitutive activity of the proximal promoter, whereas the CAMP-induced elements were not functional. In summary, the mapping experiments clearly established that the CRE, the downstream CREUO element, and the proximal promoter of the CT gene were used differently in CT-positive and CTnegative cells. 
Identification and Characterization of tramActing Factors that Bound to the CT CRE
To characterize the factors binding to the CT CRE, we performed mobility-shift assays. Incubating the CT CRE probe with lT nuclear extracts resulted in the formation of two complexes (Fig. 4) . The principal complex was completely competed by the CRE oligonucleotide, which contains the wild type consensus CRE motif (TGACGTCA), but not by the CREM oligonucleotide, which contains a mutated version of the CRE motif (TMCGGCA).
There was no clear competition with oligonucleotides containing the consensus sequence for either activator protein 1 (AP-1, 20) or AP-2 binding sites. On the autoradiogram of the gel shown in Fig. 4 , there seems to be partial competition of the CRE complex with the AP-1 oligonucleotide, but this competition was not reproducible. Thus, we were unable to demonstrate any definite binding to the CT CRE of members of the Fos/Jun protein family, although the latter can bind to a CRE after cross-heterodimerization with members of the CREB/ATF family (21).
Because the CRE sequence was identical to the CREL motif except for one base mismatch, we repeated the competition studies with the CREL oligonucleotide, which contained the CREL motif (TGACCTCA), and with the CRELM oligonucleotide, which contained a mutated version of the CRELmotif(TAACCGCA).
There was no cross-competition with either oligonucleotide.
We concluded that the proteins that bound to the CRE element specifically require the TGACGTCA motif for high-affinity binding. Moreover, these binding proteins are probably different from those that bound to the CREL motif, because there was no cross-competition between the two.
To test whether CAMP-mediated transcription involved up-regulation of CRE-binding proteins, we repeated the binding assays with the CRE probe and extracts from untreated TT cells and TT cells treated with a CAMP analog for 24 h. Treating the cells with CAMP had no effect on either the mobility or the abundance of the CRE-binding proteins (data not shown). These findings suggest that these factors respond to CAMP by modifying their transcriptional activity rather than their abundance or DNA binding (10, 11).
To identify the factors within the specific CRE complexes, we used antibodies against two members of the CREB/ATF family, CREB and ATF-1. The antibodies against CREB recognize homodimers and heterodimers of CREB, whereas the antibodies against ATF-1 recognize only ATF-1 homodimers (22). We repeated the band-shift assays, incubating lT extracts with the antibodies and the CRE probe (Fig. 4) . The ATF-1 antibodies induced a partial supershift of the CRE-protein complex, whereas preimmune serum did not. The super-shift with the ATF-1 antibodies indicated that ATF-1 was a component of the CRE-protein complex. The CREB antibodies had two effects on the CRE-specific complexes: a partial supershift and an inhibition of complex formation. We think that disruption of the CRVprotein complexes by these antibodies occurred because they were raised against a peptide in the C terminus of CREB, a region that is important for the DNA-binding activity of this protein. These results show that both CREB and ATF-1 bound to CT CRE element in lT cells. However, we cannot exclude the possibility that there are other, unidentified components of the CRE-protein complex, because both antibodies reacted only partially with the CRE-protein complexes.
Characterization of the WE-Binding Proteins in CT-Negative Cells
We next examined whether protein binding to the CRE explained the differences in CAMP-induced transcriptional activity in lT cells and the CT-negative cell lines RO-D81-1 and HeLa. We repeated the electrophoretic mobility shift assays using the CRE probe and nuclear extracts from RO-D81-1 and HeLa cells (Fig. 5A) . A DNA-binding pattern similar to the one seen with TT cells was observed. There were only minor differences in the intensities of the complexes in the extracts, suggesting that binding-protein abundance did not affect transcriptional activity of the CT CRE element in the different cells.
Further characterization with the antibodies against CREB and ATF-1 (Fig. 5B) teins from HeLa and TT cells may be one of the reasons why the combined transcriptional activity of the CT CRE and CREUO in HeLa cells was constitutive and not CAMP induced. We were unable to find any differences between the CRE-binding proteins from RO-D81-1 and lT by using the antibodies against CREB and ATF-1. Therefore our tests cannot explain the lack of CAMPinduced transcription in RO-D81-1 cells.
Characterization of Protein Binding to the Downstream CREUO Element in Tl Cells
To characterize the proteins binding to the CREUO element, we first considered the complexity of this element. As shown in Fig. 1 , it contains a CREL sequence flanked by two octamer motifs. Since these three sequences are adjacent, we realized that a mutation in one binding site might affect binding to a neighboring site. Therefore, binding pattern was first tested with the OKREUO probe (CT nucleotides -202 to -129) which contained all three sites, unmutated. Incubating this probe with nuclear extracts from cultured lT, RO-D81-1, or HeLa cells did not result in the formation of a specific complex (data not shown). This lack of binding strongly suggested that the TGACCTCA motif within the CREUO region, although similar to a CRE, was not a CREB/ATF binding site. There are two possible explanations for the lack of detection of specific binding with the lT nuclear extracts. First, the proteins binding to CT nucleotides -202 to -129 may have been present in low abundance in cultured lT cells and therefore could not be detected in crude extract. Second, the binding affinity of the transcription factors interacting with this region may be too low to be detected by the electrophoretic mobility shift assay. Because there are recorded differences in the pattern of CTKGRP gene expression in MTC tumors carried in animal models and in culture (23), we considered the possibility that transcription factors that regulate expression of the CT gene will be represented differently or perhaps more abundantly in tumors generated from lT cells than in culture. We tested extracts from 5-to 7-week-old tumors induced in nude mice by SC injection with lT cells. Figure 6 (lanes 1-5) shows that proteins from tumor extract formed one slowly migrating complex (complex 1) and three fast migrating complexes (complexes 2-4) with the O/CREL/O probe. Competition with the CREL oligonucleotide (which contains the CREL and octamer motifs) abolished complex 1 formation but had a minimal effect on formation of complexes 2-4. Somewhat surprisingly, a mutated CREL oligonucleotide (CRELM) also competed with complex 1. There was no competition of complex 1 with the AP-1 (lane 6) or the AP-2 oligonucleotides (data not shown). These results suggested that the proteins within complex 1 were probably not the Vans-activators that bound to CREL, as the proteins within this complex did not specifically require the TGACCTCA motif to bind. Because the oligonucleotide competitors ,CREL and CRELM both contained octamer motifs, we tested whether the binding site of proteins in complex 1 overlapped the upstream octamer motif. We repeated the binding assays using the CREUO probe, which contained a truncated version of the upstream octamer. Fig 6 (lanes 6-8) shows that this truncation prevented the formation of complex 1 but did not have any effect on complexes 2-4. We therefore concluded that the binding activity of the proteins within complex 1 was dependent on the upstream octamer sequences. Because the upstream octamer was not transcriptionally active in the neuroendocrine lT cells (compare pCAMP-2 to pCMAP-4 in Fig. 2 gene are in the central and peripheral nervous systems (1) it is possible that the upstream octamer and its transacting factors are active in these other cell types. We next investigated the identity of the proteins within complexes 2-4. For this, we used the CRELm/O and the CREUOm probes, which were identical to CREUO except for two-point mutations in the CREL site or three-point mutations in the downstream octamer motif, respectively. Either one of these mutations diminished transcriptional activity of the CREUO element (Fig. 2) . Examination of binding to these probes revealed that the formation of complexes 24 was abolished by the three-point mutations in the octamer sequence (Fig. 6, lanes 1 O-l 2) but not by the two-point mutations in the CREL site (Fig. 6, lanes  13-15) . We therefore concluded that complexes 2-4 probably contained octamer-binding proteins. By mutating either the CREL or the octamer motif we created binding sites for unidentified proteins (Fig.  6, lanes 10-15) . Especially noteworthy was a "CRELspecific" complex formed by mutating the downstream octamer motif (Fig. 6, lanes 10-12) . Our interpretation of these results is that mutation of the octamer motif facilitated the binding of low-affinity binding proteins to the CREL and the octamer motifs. We do not know whether these proteins are relevant to regulation of CT gene transcription.
From these experiments we concluded that both transcriptional activity of, and protein binding activity to, the CREUO motif were complex. Further studies are necessary to clarify the identity of the CREL-and octamer-binding proteins.
DISCUSSION
Our previous reports and those of others have described in great detail a constitutive neuroendocrinespecific enhancer of CT gene transcription in humans and rats (4-6, 24). In addition, a CAMP-induced enhancer was identified by other investigators, but its role in the regulation of neuroendocrine-specific CT expression was not determined (3, 8) . In the study reported here, we showed that CAMP induction of CT gene transcription was also restricted to a CT-producing neuroendocrine cell line ('IT). This transcriptional activity was attributed to a typical CRE and to a novel hybrid CREUO element that acted synergistically.
In the CT gene, neither the CRE nor the CREUO is a true enhancer element, because their combined activity depended either on the proximal CT promoter sequences or the presence of a distal upstream neuroendocrine-specific enhancer (5). A synergism between a CRE and other elements may be a common mechanism for maximizing CAMP-induced transcription of neuroendocrine genes, e.g. the interaction between CRE and an AP-2 site in the promoter of the proenkephalin gene and the synergism between the two CREs and a tissue-specific element in the proximal promoter region of the gene encoding the a-subunit of the glycoprotein hormone (25-27). Although the CT CRE is a typical binding site for the ubiquitous CREB and ATF-related transcription factors (1 l), its activity is clearly cell specific. One possible mechanism for this cell-specific regulation of CRE activity may be differential interaction of the CREB/ ATF-related factors with the CRE. For example, in HeLa cells, we found ATF-l-binding activity but not CREB-binding activity. The preferential binding of ATF-1 coincided with constitutive transcriptional activity of the CRE and CREUO motifs in these cells. A similar constitutive transcriptional activity of CREs from other genes in HeLa cells has been attributed to the predominant expression of ATF-1 and to the structure of ATF-1, which is devoid of the glutamine-rich N-terminal domain and the a-region that are essential for CAMP-induced activity of CREB (28, 29). Differential interaction of CREB/ATF with the CRE cannot account for the lack of transcriptional activity of this element in the undifferentiated CT-negative MTC RO-D81-1 cells because we found identical binding patterns for CREB and ATF-1 in extracts of these cells and of CT-positive lT cells. One explanation is provided by an analogous cell culture model, the teratocarcinoma cell line F9 (30). In the undifferentiated state, the transcriptional activity of CRE is low in F9 cells despite the presence of CREB and ATF. However, when F9 cells are induced to differentiate by treatment with retinoic acid, the CAMP-induced activity of CRE is restored. The low activity of the CRE in undifferentiated F9 cells is correlated with low levels of the regulatory subunit of protein kinase A and high levels of CBPl 00, an inhibitor of CREB action (30-32). The increase in CRE activity in the differentiated F9 cells was correlated with elevated levels of the regulatory subunit of protein kinase A and reduced levels of CBPl 00. Another explanation may be related to the dependence of CT CRE on the proximal promoter and the CREUO motif. If a CREUO-specific or promoterspecific transacting factor is absent from the CT-negative MTC line, it may also lead to diminished constitutive and CAMP-induced transcription of the CRE. These are two examples of auxiliary mechanisms that regulate the transcriptional activity of CREB/ATF family members, and they may apply to the differential activation of the CT CRE in the cell lines tested in the study reported here.
The transcriptionally active component in CT nucleotides -175 to -129 was the sequence TGACCT-CAATGCAAAT.
The activity of this element was also cell specific: it was partially active in the absence of CRE in lT cells, was completely dependent on CRE in HeLa cells, and was inactive in RO-D81-1 cells. It is possible that this sequence functions as a binding site for a single cell-specific transcription factor that has not yet been identified. However, because it contains two potential &-acting elements, one a CREL motif (TGACCTCA), and the other an octamer motif (ATG-CAAAT), we favor the hypotliesis that its transcriptional activity depends on two transcription factors, a CREL-binding protein and an octamer-binding protein. We base this hypothesis on transcription assays showing that mutations in either the CREL sequence or the octamer sequence diminished the CAMPinduced transcription attributable to that region. Further support for this hypothesis was derived from the DNA-protein interaction assays: although we were unable to clearly demonstrate binding to the TGACCTCA sequence, we did detect strong binding to the ATG-CARAT sequence. This latter binding activity was not affected by mutation in the CREL sequence but was abolished by mutating the octamer motif.
The strong homology of the octamer in the CREUO element to binding sites for POU/homeodomain proteins and the detection of octamer-binding activity suggest that CREUO is a &-acting motif for a related factor and may explain both its CAMP-induced activity and its cell-specific behavior. Several members of the POU/homeo family are regulated by CAMP, and most are involved in regulation of cell-specific transcription and differentiation (12-l 6) . Recently, an octamerbinding protein was reported to be involved in the regulation of the distal neuroendocrine-specific constitutive enhancer of the rat CT gene (24). It will be interesting to determine whether the upstream and downstream octamers are binding sites for the same transcription factors. We were unable to identify the CREL-binding protein, but our competition studies and protein interaction assays with the CRE motif clearly indicated that the CREL motif was not a binding site for members of the CREB/ ATF family, although it differs from a typical CRE by only one base. Further analysis of the complement of TGAC-CTCA revealed that it was homologous to a half-binding site for proteins of the steroid/thyroid/retinoic acid receptor family (33). Although response elements for members of this family usually contain two or more repeats of the AGGTCA motif, two members of this family act through a single motif. One is the nerve growth factor-induced binding protein (NGFI-B) (34, 35) . The other is retinoid X receptor 8, which binds to the TGAGGTCA sequence within region II of the major histocompatibility complex class I transcriptional regulatory element (36) (37) (38) . Future experiments will determine whether or not the CREL is a binding site for a protein related to the nuclear receptor family.
MATERIALS AND METHODS

Plasmid Construction
We previously described the restriction endonuclease-mediated deletions used to create pCTGH and pCTGH-1, which contain CT nucleotides -129 to +90 and -1460 to +90, respectively, attached to the GH gene (4, 5 
